BSX vs STE — Key Metrics

Metric BSX (BOSTON SCIENTIFIC CORP) STE (STERIS PLC)
Price43.64259.57
Market Cap63.26 Billion25.21 Billion
P/E (TTM)18.3430.68
P/B (Quarterly)2.5063.4
P/S (TTM)3.04.09
Net Profit Margin (TTM)16.613.4
Gross Margin (TTM)69.144.6
ROE (TTM)13.911.5
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

BOSTON SCIENTIFIC CORP
vs
 
STERIS PLC
 
BOSTON SCIENTIFIC CORP
vs
 
STERIS PLC
Performance Comparison
AI Model Recommendation
BSX · BOSTON SCIENTIFIC CORP

Greatly Outperform

84
UnderperformOutperform
STE · STERIS PLC

Greatly Underperform

-92
UnderperformOutperform
Recommendation Summary

Stock BSX is projected to greatly outperform the market, stock STE is projected to greatly underperform the market. Upfront Recommendation: BSX.

Financial Metrics
Prices delayed ~15 min
BSX Metrics STE
$43.64 Price $259.57
— Market Capitalization —
18.34 Price to Earnings Ratio 30.68
3.0 Price to Sales 4.09
18.99 Price to FCF Ratio 26.6
4.34 Price to Gross Profit 9.17
29.3 Price to R&D 212.89
7.75 Price to Current Assets 10.17

BSX vs STE at a glance

Boston Scientific Corp (BSX) and Steris PLC (STE) are both Medical Devices companies in the Healthcare sector. BSX is the larger, at $63.3 billion in market value against $25.2 billion for STE, about 2.5 times the size.

On trailing-twelve-month figures, BSX trades at 18.3 times trailing earnings and STE at 30.7; net profit margins are 16.6% and 13.4%.

The Upfront Investment model currently rates BSX Greatly Outperform and STE Greatly Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.